Current perspectives on coronavirus disease 2019 and cardiovascular disease: A white paper by the jaha editors

Ajay K. Gupta; Hani Jneid; Daniel Addison; Hossein Ardehali; Amelia K. Boehme; Sanket Borgaonkar; Romain Boulestreau; Kevin Clerkin; Nicolas Delarche; Holli A. Devon; Isabella M. Grumbach; Jose Gutierrez; Daniel A. Jones; Vikas Kapil; Carmela Maniero; Amgad Mentias; Pamela S. Miller; Sher May Ng; Jai D. Parekh; Reynaldo H. Sanchez; Konrad Teodor Sawicki; Anneline S.J.M. Te Riele; Carol Ann Remme; Barry London

doi:10.1161/JAHA.120.017013

Current perspectives on coronavirus disease 2019 and cardiovascular disease: A white paper by the jaha editors

Ajay K. Gupta, Hani Jneid, Daniel Addison, Hossein Ardehali, Amelia K. Boehme, Sanket Borgaonkar, Romain Boulestreau, Kevin Clerkin, Nicolas Delarche, Holli A. Devon, Isabella M. Grumbach, Jose Gutierrez, Daniel A. Jones, Vikas Kapil, Carmela Maniero, Amgad Mentias, Pamela S. Miller, Sher May Ng, Jai D. Parekh, Reynaldo H. SanchezKonrad Teodor Sawicki, Anneline S.J.M. Te Riele, Carol Ann Remme, Barry London

Research output: Contribution to journal › Article › peer-review

53 Scopus citations

Abstract

Coronavirus Disease 2019 (COVID‐19) has infected more than 3.0 million people worldwide and killed more than 200,000 as of April 27, 2020. In this White Paper, we address the cardiovascular co-morbidities of COVID-19 infection; the diagnosis and treatment of standard cardiovascular conditions during the pandemic; and the diagnosis and treatment of the cardiovascular consequences of COVID-19 infection. In addition, we will also address various issues related to the safety of healthcare workers and the ethical issues related to patient care in this pandemic.

Original language	English (US)
Article number	e017013
Journal	Journal of the American Heart Association
Volume	9
Issue number	12
DOIs	https://doi.org/10.1161/JAHA.120.017013
State	Published - Jun 16 2020
Externally published	Yes

Keywords

COVID-19
Cardiovascular disease
Cardiovascular risk factors
Coronavirus disease 2019
Management
SARS-CoV-2
Treatment

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1161/JAHA.120.017013

Cite this

Gupta, A. K., Jneid, H., Addison, D., Ardehali, H., Boehme, A. K., Borgaonkar, S., Boulestreau, R., Clerkin, K., Delarche, N., Devon, H. A., Grumbach, I. M., Gutierrez, J., Jones, D. A., Kapil, V., Maniero, C., Mentias, A., Miller, P. S., Ng, S. M., Parekh, J. D., ... London, B. (2020). Current perspectives on coronavirus disease 2019 and cardiovascular disease: A white paper by the jaha editors. Journal of the American Heart Association, 9(12), Article e017013. https://doi.org/10.1161/JAHA.120.017013

Gupta, AK, Jneid, H, Addison, D, Ardehali, H, Boehme, AK, Borgaonkar, S, Boulestreau, R, Clerkin, K, Delarche, N, Devon, HA, Grumbach, IM, Gutierrez, J, Jones, DA, Kapil, V, Maniero, C, Mentias, A, Miller, PS, Ng, SM, Parekh, JD, Sanchez, RH, Sawicki, KT, Te Riele, ASJM, Remme, CA & London, B 2020, 'Current perspectives on coronavirus disease 2019 and cardiovascular disease: A white paper by the jaha editors', Journal of the American Heart Association, vol. 9, no. 12, e017013. https://doi.org/10.1161/JAHA.120.017013

@article{3f93c035687042efa00a275469dc6a55,

title = "Current perspectives on coronavirus disease 2019 and cardiovascular disease: A white paper by the jaha editors",

abstract = "Coronavirus Disease 2019 (COVID‐19) has infected more than 3.0 million people worldwide and killed more than 200,000 as of April 27, 2020. In this White Paper, we address the cardiovascular co-morbidities of COVID-19 infection; the diagnosis and treatment of standard cardiovascular conditions during the pandemic; and the diagnosis and treatment of the cardiovascular consequences of COVID-19 infection. In addition, we will also address various issues related to the safety of healthcare workers and the ethical issues related to patient care in this pandemic.",

keywords = "COVID-19, Cardiovascular disease, Cardiovascular risk factors, Coronavirus disease 2019, Management, SARS-CoV-2, Treatment",

author = "Gupta, {Ajay K.} and Hani Jneid and Daniel Addison and Hossein Ardehali and Boehme, {Amelia K.} and Sanket Borgaonkar and Romain Boulestreau and Kevin Clerkin and Nicolas Delarche and Devon, {Holli A.} and Grumbach, {Isabella M.} and Jose Gutierrez and Jones, {Daniel A.} and Vikas Kapil and Carmela Maniero and Amgad Mentias and Miller, {Pamela S.} and Ng, {Sher May} and Parekh, {Jai D.} and Sanchez, {Reynaldo H.} and Sawicki, {Konrad Teodor} and {Te Riele}, {Anneline S.J.M.} and Remme, {Carol Ann} and Barry London",

note = "Publisher Copyright: {\textcopyright} 2020 The Authors.",

year = "2020",

month = jun,

day = "16",

doi = "10.1161/JAHA.120.017013",

language = "English (US)",

volume = "9",

journal = "Journal of the American Heart Association",

issn = "2047-9980",

publisher = "American Heart Association Inc.",

number = "12",

}

TY - JOUR

T1 - Current perspectives on coronavirus disease 2019 and cardiovascular disease

T2 - A white paper by the jaha editors

AU - Gupta, Ajay K.

AU - Jneid, Hani

AU - Addison, Daniel

AU - Ardehali, Hossein

AU - Boehme, Amelia K.

AU - Borgaonkar, Sanket

AU - Boulestreau, Romain

AU - Clerkin, Kevin

AU - Delarche, Nicolas

AU - Devon, Holli A.

AU - Grumbach, Isabella M.

AU - Gutierrez, Jose

AU - Jones, Daniel A.

AU - Kapil, Vikas

AU - Maniero, Carmela

AU - Mentias, Amgad

AU - Miller, Pamela S.

AU - Ng, Sher May

AU - Parekh, Jai D.

AU - Sanchez, Reynaldo H.

AU - Sawicki, Konrad Teodor

AU - Te Riele, Anneline S.J.M.

AU - Remme, Carol Ann

AU - London, Barry

PY - 2020/6/16

Y1 - 2020/6/16

N2 - Coronavirus Disease 2019 (COVID‐19) has infected more than 3.0 million people worldwide and killed more than 200,000 as of April 27, 2020. In this White Paper, we address the cardiovascular co-morbidities of COVID-19 infection; the diagnosis and treatment of standard cardiovascular conditions during the pandemic; and the diagnosis and treatment of the cardiovascular consequences of COVID-19 infection. In addition, we will also address various issues related to the safety of healthcare workers and the ethical issues related to patient care in this pandemic.

AB - Coronavirus Disease 2019 (COVID‐19) has infected more than 3.0 million people worldwide and killed more than 200,000 as of April 27, 2020. In this White Paper, we address the cardiovascular co-morbidities of COVID-19 infection; the diagnosis and treatment of standard cardiovascular conditions during the pandemic; and the diagnosis and treatment of the cardiovascular consequences of COVID-19 infection. In addition, we will also address various issues related to the safety of healthcare workers and the ethical issues related to patient care in this pandemic.

KW - COVID-19

KW - Cardiovascular disease

KW - Cardiovascular risk factors

KW - Coronavirus disease 2019

KW - Management

KW - SARS-CoV-2

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=85084617568&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85084617568&partnerID=8YFLogxK

U2 - 10.1161/JAHA.120.017013

DO - 10.1161/JAHA.120.017013

M3 - Article

C2 - 32347144

AN - SCOPUS:85084617568

SN - 2047-9980

VL - 9

JO - Journal of the American Heart Association

JF - Journal of the American Heart Association

IS - 12

M1 - e017013

ER -

Current perspectives on coronavirus disease 2019 and cardiovascular disease: A white paper by the jaha editors

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this